Rothschild Capital Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-81,600
Closed -$1.39M 65
2016
Q1
$1.39M Buy
+81,600
New +$1.36M 0.62% 39
2015
Q3
Sell
-2,400
Closed -$48K 42
2015
Q2
$48K Buy
+2,400
New +$42.2K 0.02% 46

Other funds holding DXCM

Rothschild Capital Partners's DXCM Position: Q1 2023 in Review

Rothschild Capital Partners sold out of DexCom (DXCM) in Q1 2023, closing a stake of 23,243 shares — an estimated $2.6M sold.

Rothschild Capital Partners first reported a position in DXCM in Q2 2013 and held it in 29 quarters. The position peaked at $13.8M in Q4 2014. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Rothschild Capital Partners reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Rothschild Capital Partners sold 23,243 DexCom shares in Q1 2023, an estimated $2.6M.
  • Rothschild Capital Partners first reported a position in DexCom in Q2 2013 and held it in 29 quarters.
  • Rothschild Capital Partners's DexCom position peaked at $13.8M in Q4 2014.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Rothschild Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.